ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2021$97,000
-97.3%
19,324
-85.8%
0.00%
-100.0%
Q4 2020$3,548,000
-23.7%
136,477
+9.1%
0.01%
-28.6%
Q3 2020$4,649,000
-27.5%
125,062
+0.1%
0.01%
-41.7%
Q2 2020$6,410,000
+432.8%
124,931
+227.6%
0.01%
+300.0%
Q1 2020$1,203,00038,1390.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders